|
13 Nov 2007 |
New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models
|
|
12 Nov 2007 |
Major Phase 3 Trial Shows Zevalin(R) Extends Progression-Free Survival in one of the most common types of Lymphoma
|
|
09 Nov 2007 |
Biogen Idec's Baminercept, the First Lymphotoxin-beta Pathway Inhibitor in Development, Shows Promise in Patients with Rheumatoid Arthritis
|
|
09 Nov 2007 |
Human Genome Sciences Reports Positive Data From Long-Term Treatment With LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus
|
|
09 Nov 2007 |
Seattle Genetics Initiates Phase IIb Clinical Trial of SGN-33 in Combination with Chemotherapy for Acute Myeloid Leukemia
|
|
08 Nov 2007 |
Dyax Corp. Announces Extension of Antibody Library Collaboration with ImClone Systems
|
|
08 Nov 2007 |
A Second Overseas Phase III Trial Data Demonstrates Efficacy of "Actemra(R)"
|
|
08 Nov 2007 |
Abbott Research Demonstrates Viability of Combining Antibody Functions to Target Two or More Disease-Causing Processes
|
|
08 Nov 2007 |
Trubion Pharmaceuticals Announces Presentation of Positive Data From Phase IIb and Re-treatment Studies With TRU-015 in Patients With Rheumatoid Arthritis
|
|
06 Nov 2007 |
Micromet's BiTE(R) Antibodies Reveal Unique Mode of Action
|
|
06 Nov 2007 |
Millennium Announces MLN1202 Significantly Reduced Marker of Systemic Inflammation and Identifies Genomic Biomarker For Responders
|
|
05 Nov 2007 |
Positive Results From Peregrine Pharmaceuticals' Bavituximab Phase l HCV Trial Presented at AASLD Meeting
|
|
03 Nov 2007 |
ThromboGenics and BioInvent Announce Publication of Exciting Data on a Novel Class of Angiogenesis I
|
|
02 Nov 2007 |
Seattle Genetics Initiates SGN-40 Clinical Trial in Combination with Revlimid for Multiple Myeloma
|
|
01 Nov 2007 |
Seattle Genetics and MedImmune Expand Antibody-Drug Conjugate Collaboration
|
|
30 Oct 2007 |
Ono and Medarex Announce Allowance of Investigational New Drug Application for Fully Human Anti-PD1 Antibody
|
|
29 Oct 2007 |
Peptech successfully completes Phase I trial for PN0621
|
|
26 Oct 2007 |
Novel Alternative Approach to Inhibiting Insulin Growth Factor (IGF) May Provide New Treatment for Breast Cancer and Other Cancers
|
|
26 Oct 2007 |
Arius announces new findings in Trop-2 and CD59 CANCER antibody programs
|
|
25 Oct 2007 |
Human Genome Sciences presents new data showing anti-tumor activity and safety of trail receptor antibodies in combination with chemotherapy
|
|
25 Oct 2007 |
Milatuzumab Showed Promising Therapeutic Effects Alone and Combined With CD20 Antibody in Preclinical Studies
|
|
25 Oct 2007 |
ImmunoGen, Inc. Reports New Clinical and Preclinical Data at AACR-NCI-EORTC
|
|
25 Oct 2007 |
Seattle Genetics Reports Preclinical Data on SGN-40 and an Anti-CD19 Antibody-Drug Conjugate
|
|
25 Oct 2007 |
CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma
|
|
24 Oct 2007 |
ARIUS announces cancer stem cell antibody program successfully completes first toxicology study
|
